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Single-chain heterodimerThe papillomavirus life cycle is regulated by a family of proteins encoded by the E2 open reading frame; E2
proteins regulate viral gene expression, DNA replication and genome maintenance. We have previously
shown that the bovine papillomavirus (BPV1) full-length E2 protein forms heterodimers with repressor forms
of E2, and these E2 heterodimers serve as activators of transcription and replication during the viral life cycle.
In the present study, using the single-chain E2 heterodimer as a model, we show that human papillomavirus
(HPV) 11 and 18 E2 heterodimers with single activation domain are able to initiate replication of URR-
containing plasmid in transient assay. Single-chain E2 heterodimer in the context of HPV18 genome initiates
genome replication, but is not sufﬁcient for long-term replication of HPV18 genome. We also show that
HPV18 genome has a capacity to encode truncated E2 repressor E8/E2 which acts as a negative regulator of
HPV18 genome replication.iversity of Tartu, Nooruse 1,
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Papillomaviruses are small double-stranded DNA viruses that are
capable of infecting epithelia and inducing benign lesions. To date,
more than 100 different types of papillomaviruses have been
identiﬁed; each virus infects a speciﬁc region of cutaneous or mucosal
epithelium in its host. These infections are usually persistent;
papillomaviruses are capable of maintaining their viral genomes as
low-copy number extrachromosomal plasmids in dividing cells.
The papillomavirus E2 protein is sequence-speciﬁc DNA binding
protein that is involved in the initiation of DNA replication, control of
viral transcription, and segregation of viral genomes (Ilves et al., 1999;
Spalholz et al., 1985; Ustav and Stenlund, 1991). In initiation of viral
DNA replication, the regulatory E2 protein helps to recruit the viral
helicase E1 to the viral replication origin by protein–protein and
protein–DNA interactions (Sedman and Stenlund, 1995). The viral E2
protein is also a transcriptional modulator with dual activities: the
best studied bovine papillomavirus type 1 (BPV1) E2 protein is a
transcription activator which regulates transcription of viral early
promoters through binding to E2 binding sites (E2BS) (Spalholz et al.,
1985), while human papillomavirus (HPV) E2 proteins repress the
viral E6 and E7 promoter from promoter-proximal E2BS (Thierry and
Yaniv, 1987). HPV E2 activates replication and at the same time
represses transcription by binding to the same sites.Papillomavirus genomes encode at least two different E2 proteins.
Similar to BPV1, HPV 11, 16 and 31 have been shown to encode
mRNAs coding for short forms of the E2 protein (Chiang et al., 1991;
Hubbert et al., 1988; Lace et al., 2008; Stubenrauch et al., 2000). For
BPV1, mRNA for E2C is transcribed from a promoter internal to the
open reading frame, and the other, E8/E2, is created by splicing E8 ORF
sequences to an acceptor located within the E2 ORF. The putative
repressor proteins encoded by HPVs are similar to the BPV1 E8/E2
protein, since they contain a small conserved E8 ORF (HPV 31, 16, 11)
or fragment of E1 ORF (HPV 11) fused to the C-terminus of E2. All E2
repressor proteins lack the amino-terminal domain of E2 responsible
for regulation of transcription and DNA replication, but retain the
carboxy-terminal domain that mediates speciﬁc DNA recognition and
dimerization. Transient over-expression assays have suggested that
repressor proteins act as negative regulators of E2-dependent
transcriptional activation and plasmid replication, antagonizing E2
by competing with E2 binding at E2BSs (Chiang et al., 1991; Lim et al.,
1998; Stubenrauch et al., 2000). In addition, the E8 domain of HPV31
E8^E2 protein itself is a transcriptional repressor domain that
functions independently of binding site competition and heterodimer
formation (Zobel et al., 2003) inhibiting transcription and DNA
replication by interaction with corepressor molecules (Ammermann
et al., 2008). Genetic experiments have shown the importance of E2
repressor proteins in the modulation of viral DNA replication and
plasmid copy number (Lace et al., 2008; Lambert et al., 1990;
Stubenrauch et al., 2000). Knockout of E8^E2 in the context of
HPV31 and HPV16 genome led to increase in the transient DNA
replication level. These experiments demonstrated that HPV31 E8^E2
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maintenance (Lace et al., 2008; Stubenrauch et al., 2000).
Our recent works with BPV1 E2 proteins have shown that the full-
length E2 protein forms heterodimers with repressor forms of E2, and
suggested that these E2 heterodimers serve as activators of tran-
scription and replication during the viral life cycle (Kurg et al., 2006).
BPV1 E2 heterodimer with single activation domain is sufﬁcient for
the interaction with viral helicase E1, and is able to activate
papillomavirus DNA replication in the context of entire BPV genome
in the absence of other E2 proteins. Single-chain E2 heterodimer
protein could support transient, but not long-term, replication whenFig. 1. (A) Schematic representation of E2 proteins used in this study. Epitope tag E2Tag and c
E2 protein. (B) Western blot analysis showing increased HPV E2 protein levels in COS-7 cell
asterisk. (C) Immunoblot analysis of single-chain E2 heterodimers. The lysates of COS-
immunoblotted with HRP-conjugated anti-E2Tag antibody. Non-speciﬁc signal with cellular p
and single-chain E2 to radiolabeled E2 binding site was determined by a gel retardation ass
HPV18 E2 proteins. Protein–DNA complexes were resolved on 6% PAGE. Non-speciﬁc signa
arrows.expressed from the entire viral genome (Kurg et al., 2009). BPV1 E2
homo- and heterodimers with single activation domain interact
differently with cellular Brd4 protein (Cardenas-Mora et al., 2008;
Kurg et al., 2006), which is required for E2-mediated transcriptional
activation, and for efﬁcient mitotic chromosome association and
partitioning of BPV1 genomes (Baxter et al., 2005; Ilves et al., 2006). In
spite of this, single-chain BPV1 E2 heterodimer is able to function as a
transcription activator and activate transcription from the authentic
BPV1 promoter (Kurg et al., 2006).
In this study, we have analyzed the functional activities of HPV11
and HPV18 E2 heterodimers with single activation domain. Using theodon optimized sequence is indicated. Numbers correspond to amino acids of respective
s after partial codon optimization. Non-speciﬁc signal with cellular protein is shown by
7 cells transfected with E2 expression plasmids were subjected to SDS-PAGE and
rotein is shown by asterisk. (D) DNA binding assay. The sequence-speciﬁc binding of E2
ay using cell extracts of COS-7 cells transfected with expression plasmids for BPV1 and
l with cellular protein is shown by asterisk and the location of E2-DNA complexes by
Fig. 2. The transcription repression function of native and with codon optimized
sequence of HPV E2. U2OS cells were transfected with increasing amounts of expression
vectors (0.1 ng, 1 ng, 10 ng, 100 ng and 1000 ng) for HPV11 (A) and HPV18 (B) E2
proteins, and their E2-responsive reporter plasmid URR-Luc containing the native HPV
URR, and non-speciﬁc reporter pRL-TK. At 30 h posttransfection, cell lysates were
prepared and analyzed for luciferase activity. Luciferase activity levels were measured
and normalized to those for Renilla luciferase expression from the non E2-speciﬁc
thymidine kinase promoter of co-transfected plasmid pRL-TK. The data are presented as
promoter activities relative to those for the reporter alone and are averages of results
from three independent transfections.
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HPV E2 heterodimer with single activation domain is able to initiate
replication of URR-containing plasmid in transient assay. E2 hetero-
dimer with single activation domain in the context of HPV18 genome
initiates HPV18 genome replication, but is not sufﬁcient for long-term
replication of HPV18 genome.We also show that HPV18 genome has a
capacity to encode truncated E2 repressor protein E8/E2 which serves
as a negative regulator of HPV18 genome replication.
Results
Codon optimization and construction of E2 heterodimers with single
activation domain
HPV E2 proteins are expressed at very low levels and sometimes
remain below the detection level of Western blot analysis. To increase
their expression level, the 5' ends of HPV11 and HPV18 ORFs were re-
synthesized to change the codons to those most frequent in
mammalian cells (Oliveira et al., 2006). In order to compare the
expression levels of different E2 proteins, we have fused the E2Tag,
derived from the BPV1 E2 protein (SSTSSDFRDR, aa 199–208) (Kurg et
al., 1999) at the N-termini of HPV11 and HPV18 E2 proteins. As shown
in Fig. 1B, codon optimization (co) increased drastically the
expression level of HPV11 and HPV18 E2 proteins in COS-7 cells,
and made it comparable to the expression of BPV1 E2 protein (Fig. 1C,
lanes 2, 4, 7). Similar results were obtained in human U2OS cells (data
not shown).
The HPV E2 “single-chain heterodimers” (sc) were constructed by
fusing the coding region of C-terminal DBD in frame to the full-length
E2 as depicted for BPV1 E2 protein (Kurg et al., 2006). Two single-
chain variants, with 5 and 21 residues linkers (scE2co-5 and scE2co-
21, respectively), were constructed. The 21 bp linker is glycine-rich
(GSGGGGGSGGGGS) to achieve maximum ﬂexibility for correct
folding of the protein (Dellarole et al., 2007; Kurg et al., 2006). As
shown in Fig. 1C, all proteins expressed at similar levels and migrated
at the expected sizes. The ability of synthetic single-chain E2 protein
to bind DNA was tested in a gel shift assay with the lysates of
transfected COS-7 cells. HPV18E2co and HPV18scE2co-21 were both
able to bind to double-stranded E2 binding site (Fig. 1D, lanes 4, 5)
and gave a mobility shift similar to that of BPV1 E2 proteins. These
data demonstrated that both, the full-length HPV18E2co and
HPV18scE2co with single activation domain can bind DNA sequence
speciﬁcally, suggesting that they are correctly folded and functional.
E2 heterodimers with single activation domain repress the HPV
early promoter
To ensure that the HPV11E2co and HPV18E2co proteins are
functional, the proteins were tested in transcription assay using
dual-luciferase reporter assay system (Promega). The HPV URR-
containing luciferase reporters were co-transfected with pCG plasmid
encoding E2 and with pRL-TK, a non-speciﬁc reporter, into U2OS cells,
and the luciferase activities weremeasured. The data of E2-responsive
ﬁreﬂy luciferase expression were normalized to the data of E2-non-
speciﬁc Renilla luciferase expression and the results are presented
relative to basal activity (no E2 protein). The HPV E2 proteins are
repressors of their native promoter, and the concentration-dependent
repression of URR-containing luciferase constructs was seen in the
case of all E2 proteins (Fig. 2). Similar results were obtained in HaCaT
cell line (data not shown). As expected, the same amounts of E2 and
E2co plasmids resulted in different effects. For instance, 10 ng of HPV
E2co plasmid repressed strongly the HPV URR reporter, while the
same amount of HPV E2nat plasmid had minimal effect (Fig. 2). These
results are consistent with the increased expression level of E2co
proteins and conﬁrmed that we can use lower amounts of expression
plasmids in functional assays.To address whether HPV E2 protein with single activation domain
is able to repress the HPV natural promoter, the HPV URR-Luc plasmid
was transfected with increasing concentrations of E2co expression
plasmids into U2OS cells. As shown in Fig. 3, both single-chain
proteins, HPV11scE2co and HPV18scE2co, repressed their respective
URR-Luc reporters similar to full-length HPV11E2co and HPV18E2co
proteins (Fig. 3). These data show that the transcription repression
function of HPV E2 single-chain heterodimer is comparable with that
of the full-length E2 protein with two activation domains.
E2 heterodimers with single activation domain initiate replication of
URR-containing plasmid
The E2 protein is able to support papillomavirus DNA replication
and next we tested the ability of E2 heterodimers with single
activation domain to support the replication of HPV origin containing
plasmids in transient replication assay. The expression plasmid for
single-chain E2 proteins were cotransfected with HPV18 or -11 URR
containing plasmid and expression plasmid for respective E1 protein
into U2OS cells by electroporation, and the lowmolecular weight DNA
was isolated and analyzed as depicted in Ustav and Stenlund (1991).
As shown in Fig. 4, both single-chain E2 heterodimers were able to
support the replication of HPV 11 and 18 origin containing plasmids
similar to full-length HPV E2 proteins. Similar results were obtained in
human C33A and hamster CHO cells (data not shown).
Fig. 3. HPV E2 heterodimers with single activation domain repress the HPV early
promoter. U2OS cells were transfected with expression vectors for E2co, scE2co or DBD
of HPV11 (A) and HPV18 (B), their E2-responsive reporter plasmid URR-Luc, and pRL-
TK. Luciferase activity levels were measured and normalized to those for Renilla
luciferase expression. The data are presented as promoter activities relative to those for
the reporter alone and are averages of results from three independent transfections.
Fig. 4. HPV E2 heterodimers with single activation domain initiate replication of URR-
containing plasmid. Expression plasmids for E2co, scE2co or DBD were co-transfected
with URR-containing plasmid and expression vector for E1 of HPV11 (A) and HPV18 (B)
into U2OS cells. The cells were harvested 48 and 72 h after electroporation. Episomal
DNA was isolated, digested with DpnI and linearizing enzyme, and analyzed by
Southern blotting using a radiolabeled probe speciﬁc for the reporter plasmid. The
linearized reporter plasmid as a marker is shown on the left.
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HPV16 and 31 have been shown to encodemRNAs coding for short
forms of the E2 protein (Lace et al., 2008; Stubenrauch et al., 2000).
Next we tested for the presence of HPV18 E8^E2C (18-E8^E2C)
transcripts in our system, in U2OS cells transfected with the HPV18
genome. Total RNA was isolated 72 h after electroporation, reverse
transcribed and ampliﬁed with primers from the 5’ part of the E1
region (nt 1313 to 1332), upstream of the E8 ORF, and the 3’ region of
E2 at nt 3582 to 3601. The predicted 18-E8^E2C spliced product was
detected (Fig. 5B), and the sites for the splice donor (SD) at nt 1357
and the splice acceptor (SA) at nt 3434 were conﬁrmed by sequence
analysis of the puriﬁed ampliﬁcation product (Fig. 5D). Analysis of 18-
E8^E2C transcript revealed that the putative 18-E8^E2C protein fuses
11 aa from E8 ORF to aa 212 of E2 ORF, and contains the conserved K5,
W6 and K7 residues required for E8^E2C protein repressor activity
(Zobel et al., 2003). These data suggest that the HPV18 genome
encodes the 18-E8^E2C transcript similar to other alpha-papilloma-
viruses, and that the putative 18-E8^E2C protein may act as a
repressor similar to the other E8^E2C proteins studied so far.
To genetically investigate the role of 18-E8^E2C protein, we
changed the E8 ATG codon to ACG in the context of the HPV18
genome. This mutation did not change amino acids in overlapping E1
replication gene. The wild-type HPV18 genome and HPV18/E8-
genomes were transfected into the human U2OS cells and episomal
DNA was extracted and analyzed by Southern blotting, as described
earlier (Kadaja et al., 2009). The replicated HPV18 genome, which is
resistant to DpnI cleavage, was detected 3 days after electroporation
(Fig. 6A, B; lane 3), and as expected, mutation of the E8 ATG led to a
dramatic increase in DNA replication levels (Fig. 6B; lane 3). We
followed the replication of HPV18 genomes in U2OS cells within
2 weeks splitting the cells after every 3 days. As shown in Fig. 6B, the
replication signal of HPV18/E8- genome started to drop after day 6
while the wild-type HPV18 genome replicated at constant copynumber within the 2 weeks of experiment. These data conﬁrm that
18-E8^E2C protein is a negative regulator of viral DNA replication, and
HPV18 genomes unable to express E8^E2C could not be maintained in
dividing cells.
E2 heterodimer with single activation domain initiates HPV18 genome
replication, but is not sufﬁcient for long-term maintenance
In order to follow the ability of scE2 heterodimer to support
papillomavirus DNA replication in the context of the HPV18 genome,
we have replaced the open reading frame of E2 with scE2 sequence in
the HPV18 and HPV18/E8- genomes. The mutated HPV18scE2
genome encodes E2 proteins with two DNA-binding domains, and
as a result two different E2 proteins; E2 heterodimer with single
activation domain and with single E8 domain are formed. HPV18/E8-
scE2 genome encodes only single-chain E2 protein. Here we have
used the sequence of native E2 gene to ensure the balance of
expression level of viral E1 and E2 proteins from HPV18 genome. We
also analyzed the presence of E1 transcript transcribed from wt and
HPV18scE2 genomes. E1 mRNA was detected 72 h after electropora-
tion, and as shown in Fig. 5C, mutation of HPV18 genome has not
changed the transcription of HPV18 E1 mRNA. Next the wild-type and
mutated HPV18 genomes were transfected into the human U2OS cells
and the lowmolecular weight DNAwas isolated at days 3, 6, 9, 12 and
15. The wt HPV18 genome was able to replicate and maintain in
dividing U2OS cells up to 2 weeks, while HPV18scE2 and HPV18/E8-
scE2 genomes expressing single-chain E2 proteins disappeared
Fig. 5. HPV18 genome encodes E8^E2 transcript. (A) HPV18 E8^E2 transcript is created
by using the splice donor site at nt 1357 in E8 ORF and the splice acceptor at nt 3434
within the E2 ORF. Location of primers is indicated by arrows. (B) U2OS cells were
transiently transfected with wild-type or mutated HPV18 genome. Total RNA was
isolated 72 h after electroporation, reverse transcribed, ampliﬁed with primers 18E1F
and 18E2L1 and analyzed by gel-electrophoresis. The DNA marker is shown on the
right. (C) Transcription of HPV18 E1 mRNA in U2OS cells transiently transfected with
wild-type or mutated HPV18 genome. Total RNAwas isolated 72 h after electroporation
and reverse transcribed. cDNA was ampliﬁed with primers 18E1F and 18E1R and
analyzed by gel-electrophoresis. (D) Sequence analysis of the puriﬁed ampliﬁcation
product of E8^E2C transcript. The putative HPV18 E8^E2C protein fuses 11 aa from E8
ORF to aa 212 of E2 ORF.
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domain in the context of entire HPV18 genome is able to initiate the
viral DNA replication, but is not sufﬁcient for long-term replication of
HPV18 genome.Fig. 6. E2 heterodimer with single activation domain in the context of HPV18 genome
initiates HPV18 genome replication, but is not sufﬁcient for long-term replication of
HPV18 genome. (A) Schematic representation of HPV18 genomes used in this
experiment. (B) U2OS cells were transfected with wt HPV18 genomes or HPV18/E8-
genomes expressing either E2 or scE2, and harvested 3, 6, 9, 12 and 15 days after
electroporation. Episomal DNA was isolated, digested with DpnI and linearizing
enzyme, and analyzed by Southern blotting using a radiolabeled probe speciﬁc for the
HPV18 genome plasmid. The HPV18 genome cut with linearizing enzyme EcoRI and
DpnI are used as markers.Discussion
In the present work, we have studied the functioning of HPV E2
heterodimers with single activation domain. Using the single-chain E2
heterodimer as a model, we show that HPV E2 heterodimer is able to
initiate replication of URR-containing plasmid and HPV18 genome.
However, HPV18 genomes expressing single-chain E2 proteins could
not be maintained extrachromosomally in long-term assays showing
the single activation domain is not sufﬁcient for long-term replication
164 R. Kurg et al. / Virology 408 (2010) 159–166of HPV18 genomes. These data support the hypothesis that the full-
length E2 homodimer is required for the long-term replication of HPV
genomes.
E2 heterodimer with single activation domain is able to initiate the
replication of HPV origin-containing plasmid and HPV18 genome. This
result is consistent with earlier studies showing that single activation
domain of E2 is sufﬁcient for initiation of DNA replication in concert
with viral helicase E1 (Hernandez-Ramon et al., 2008; Kurg et al.,
2006, 2009; Lim et al., 1998) and conﬁrms that the replication
initiation function of E2 proteins is conserved between different types
of papillomaviruses. In our study, the ability to initiate replication is
comparable between full-length and single-chain E2 proteins using
URR-containing plasmids. However, in the context of viral genome,
HPV18scE2 genome expressing the single-chain E2 heterodimer
replicated weaker than the wild-type HPV18 genome while the
amount of E1 transcript initiated at p105 promoter was comparable in
cells containing either HPV18 genome or mutated one. The HPV18
E8^E2C protein is a negative regulator of replication and it is possible
that E8^E2C coded by the genome acts as a dominant negative
regulator inhibiting the action of single-chain E2 heterodimer better
than that of the full-length E2 homodimer. However, we cannot rule
out the possibility that HPV E2may directly or indirectly inﬂuence the
cellular environment and make it favourable for virus extrachromo-
somal replication, and this function is characteristic for full-length E2
dimer only. For instance, the pro-apoptotic function of high-risk HPV
E2s requires two functional N-terminal domains in order to induce
cell death (Webster et al., 2000) with no involvement of its
transcriptional functions (Demeret et al., 2003).
The full-length E2 protein with two activation domains is required
for HPV persistent replication, the single-chain E2 heterodimer is not
sufﬁcient for this activity. On the other hand, elimination of E8^E2C
repressor protein gives a similar genome replication phenotype even
though the full-length E2 homodimer is present (Fig. 6). The episomal
genome maintenance of alpha-papillomaviruses is a complex process
which is not yet fully understood. Our data suggest that this is a
complex process which is regulated at least by two different levels;
ﬁrst, through interactions with cellular factors, and second, through
the concentration of functional E2 homodimer in the nucleus of the
cell. For BPV1, the E2 protein acts as a tether linking the viral genome
to cellular mitotic chromosomes through interactions with cellular
binding partners, one of which is Brd4 (You et al., 2004). The exact
mechanism of maintenance of HPVs in dividing keratinocytes is still
not known, but recent studies have suggested that alpha-papilloma-
viruses may target different cellular binding partners (McPhillips et
al., 2006). We assume that the intact E2 homodimer with two
functional activation domains is needed for these still unknown
interactions. On the other hand, our data support the hypothesis that
Brd4 is also involved in the maintenance of alpha-papillomaviruses in
dividing cells as E2 heterodimer with single activation domain is
crippled in Brd4 binding (Kurg et al., 2006).
HPV E2 protein is primarily a repressor when expressed from the
background of the viral genome in human keratinocytes (Soeda et al.,
2006). Transcriptional repression requires an intact DNA binding
domain and a competent transactivation domain, and speciﬁc binding
of the E2 protein to sites in the URR (Soeda et al., 2006) (Goodwin
et al., 1998). We did not see any differences between the repression
activities of full-length and single-chain E2 proteins in transient
reporter assay, HPV E2 proteins with single activation domain were
able to repress the HPV natural promoter similar to full-length E2
proteins. In the case of BPV1, E2 homo- and heterodimers with single
activation domain interact differently with cellular Brd4 protein
(Cardenas-Mora et al., 2008; Kurg et al., 2006), which is required for
E2-mediated transcriptional activation (Baxter et al., 2005; Ilves et al.,
2006), however, single-chain E2 is still able to activate transcription
from the authentic BPV1 promoter (Kurg et al., 2006). This suggests
that there are several different cellular factors which mediate thetranscription function of E2. Recent studies using siRNA approach
have also shown that E2 recruits and coordinates the activities of
several distinct cellular pathways to down-regulate the expression of
the papillomavirus early genes (Smith et al., 2010).
Recent works have shown that the activity and amount of
functional full-length E2 protein must be very tightly regulated in
order to achieve extrachromosomal maintenance of viral genomes in
dividing cells. BPV1 and mucosal HPVs encode truncated E2 repressor
proteins that counteract the activity of full-length E2 and through this
regulate the activity of E2. We have mapped the HPV18 E8^E2C
transcript encoding the truncated E2 repressor protein from tran-
siently transfected cells, and show that similar to other HPV repressor
proteins HPV18 E8^E2C protein functions as a strong negative
regulator of initial plasmid ampliﬁcation (Lace et al., 2008; Stuben-
rauch et al., 2000). The role of E2 repressors in the replication cycle of
HPVs is to modulate the activity of full-length E2 protein by
preventing the E2 binding to E2BS via binding site competition, and
second, by acting as an active repressor molecule (Ammermann et al.,
2008). However, in contrast to BPV1 (Kurg et al., 2006), the
abundance of truncated HPV E2 repressor is low (Lace et al., 2008)
suggesting that additional mechanisms are involved in control of
functional HPV E2 protein level within the cell. In the present work,
we show that the different codon usage between the viral and the
human genomes accounts for the poor expression of HPV E2. A huge
enhancement of protein expression due to partial codon optimization
was observed in human, monkey and hamster cells. Similar results for
HPV11 and HPV31 E2 have been published earlier (Oliveira et al.,
2006), and enhanced expression by codon optimization has also been
shown for HPV16 E7 and E5 (Cid-Arregui et al., 2003; Disbrow et al.,
2003). Thus, the nonhuman codon bias of certain HPVs seems to be
another mechanism to control the activity of early viral genes and to
establish the extrachromosomalmaintenance of HPV in keratinocytes.
Materials and methods
Plasmids
BPV1 E2 expression vectors pCGE2 and pCGE2~DBD(310),
expressing scE2, have been described previously (Kurg et al., 2006;
Ustav and Stenlund, 1991). HPV18 and 11 E2 expression vectors
pQM18E2 and pQM11E2, E1 expression vectors pMH18E1 and
pMH11E1, and pUC18URR and pUC11URR plasmids have been
described in (Kadaja et al., 2007). Plasmids pQM18E2co and
pQM11E2co were obtained by exchanging the N-terminal 426 bp of
HPV18 E2, and 480 bp of HPV11 E2, respectively, with codon
optimized sequences (GeneArt AG). All the HPV18 and 11 E2 proteins
contain the N-terminal epitope tag E2Tag SSTSSDFRDR derived from
BPV1 E2 (aa 199 to 208).
The HPV E2 single-chain heterodimers were constructed similar to
BPV1 scE2 constructs (Kurg et al., 2006). First, the stop codon of E2 was
deleted and additional restriction sites for SalI and BamHI were created
by PCR. BamHI site was used to clone PCR-generated fragments coding
HPV18DBD (5’ CTGGATCCGGTGCAGCTACACC) and HPV11DBD (5’
CTGGATCCGTCACTGACAATTACAAC), and SalI site to clone double-
stranded oligonucleotide linker encoding the polypeptide tether (5’
TCGACGGGGGATCAGGCGGAGGTGGAGGATCCGGTGGCGGTGGCTCTC)
for pQM18scE2co-21 and pQM11scE2co-21 constructs. Constructed
coding regions were veriﬁed by sequencing. pQM11DBD and
pQM18DBD contain the DNA-binding domain of theHPV18 E2 (starting
from aa 273) andHPV11 E2 (starting from aa 285) protein, respectively,
in frame with N-terminal epitope tag E2Tag, and were constructed
by PCR.
Plasmid pBR-HPV18 contains the EcoRI-linearized full-length
HPV18 genome in the context of pBR322 vector. In pBR-HPV18scE2
plasmid, the HPV18 E2 coding region was replaced with the scE2
coding region from pQM18E2co-5. Constructed coding regions were
165R. Kurg et al. / Virology 408 (2010) 159–166veriﬁed by sequencing. The following synthetic oligonucleotide
primer was used to introduce mutation into the HPV18/E8-:
AGTGGCTAcGGCTGTTCTGAAGTGG. The wild-type sequence is capi-
talized, while nucleotide substitution is given in lowercase letter.
pGL18URR and pGL11URR plasmids were constructed by inserting
the URR region [nt 6930 to 123 from theHPV18 genome (AY262282.1);
nt 7073 to 99 from the HPV11 genome (M14119.1)] into pGL3 vector in
front of the Photinus pyralis luciferase coding sequence. pRL-TK plasmid
was purchased from Promega.
Cell lines and transfection
COS7 and U2OS cells were cultured in Iscove's modiﬁed Dulbecco's
medium, supplemented with 10% fetal calf serum. The transfections
were carried out either by electroporation as described in (Ustav et al.,
1991), applying 180 V or by lipofection using Lipofectamine™ 2000
according to manufacturer's protocol (Invitrogen).
Replication assay
For transient replication assay, U2OS cells were electroporated
with 100 ng of pUC18URR or pUC11URR plasmids, 250 ng of
pMH18E1 or pMH11E1, and 50 ng of pQM18E2co or pQM11E2co.
Low molecular weight DNA was isolated 48 and 72 h after
transfection, cut with DpnI and linearizing enzyme HindIII, and
analyzed by Southern blot analysis as described in (Ustav and
Stenlund, 1991). For HPV18 genome replication, 5 μg of pBR-HPV18
was cut with EcoRI, and the HPV18 genome excised from the pBR
vector was puriﬁed from the agarose gel, re-ligated and electro-
porated into U2OS cells. Low molecular weight DNA was isolated and
analyzed as described above. For long-term assay, cells were split after
every 3 days.
Transcription assay
U2OS and HaCaT cells were transfected with 25 ng of pRL-TK,
100 ng of E2-responsive reporter plasmid pGL18URR or pGL11URR,
and different concentrations of HPVE2 expression plasmids by
Lipofectamine™ 2000. The cells were harvested 30 h after transfec-
tion, lysed by freezing-thawing, and luciferase activity was analyzed
by a TD-20/20 luminometer (Turner Designs), following the Dual-
Luciferase reporter assay manuals (Promega).
Immunoblotting and DNA binding assay
For immunoblotting analysis, COS-7 cells, transfected with 500 ng
of E2 expression plasmids, were lysed 24 h after electroporation, and
proteins were separated by SDS-polyacrylamide gel electrophoresis
and transferred by a semidry blotting method to a polyvinylidene
diﬂuoride membrane (Millipore Corp.). Membranes were incubated
with HRP-conjugated anti-E2Tag antibody 5E11 (Kurg et al., 1999).
Detection was performed using an ECL detection kit (Amersham
Pharmacia Biotech) following the manufacturer's manual.
For DNA binding assay, 106 COS-7 cells were electroporated with
250 ng of pCGE2 or pCGE2 ~DBD(310), and pQM18E2co or
pQM18scE2co. Twenty-four hours later, the cells were collected and
lysed in 100 μl of lysis buffer (20 mM Tris–HCl, pH 8.0, 30 mM KCl,
400 mM NaCl, 0.1 mM EDTA, 0.5% TritonX-100, 10 mM dithiotreitol,
5% glycerol, and protease inhibitors) on ice for 30 min. The cell debris
were removed by centrifugation and the supernatant was used for
DNA binding assay as described in (Abroi et al., 1996) with
modiﬁcations. 2 μl of cell lysate was incubated with double-stranded
radiolabeled HPV E2BS (5’ GATCCGACCGTTTTCGGTACG) in DNA
binding buffer (20 mM Hepes, pH 7.9; 2.5 mM KCl, 5 mM MgCl2,
1 mM dithiotreitol, 0.1% NP-40, 10% glycerol, and protease inhibitors)
supplemented with 4 mg of bovine serum albumin and 0.5 mg ofsalmon sperm DNA per ml at room temperature for 15 min. Protein–
DNA complexes were resolved and analyzed as described previously.RNA analysis
RNAwas isolated fromU2OS cells 24 and 72 h after transfectionwith
circularized HPV18 genome with TRIZol® reagent (Invitrogen) accord-
ing to the directions of the manufacturer. Five micrograms of total
cellular RNA was used in reverse transcription reactions with oligo
(dT)18 primers using First Strand cDNA Synthesis Kit (Fermentas). The
reaction products were treated with RNase H (Fermentas). HPV18
cDNAs were ampliﬁed from 1/10 of the cDNA with primers 18E1F (5’
GATAGTGGCTATGGCTGTTC), 18E1R (5’ GCTGTTGTTGCCCTCTGTG) and
18E2L1 (5'GGTCCACAATGCTGCTTCTC) using recombinant Taq DNA
Polymerase (Fermentas), and analyzed by gel-electrophoresis and
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